Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products

Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
State: Maryland
Type of Government: Federal
FSC Category:
  • A - Research and development
NAICS Category:
  • 325412 - Pharmaceutical Preparation Manufacturing
Posted Date: Jan 14, 2025
Due Date: Feb 3, 2025
Solicitation No: 75N95025R00005
Original Source: Please Login to View Page
Contact information: Please Login to View Page
Bid Documents: Please Login to View Page

Description

Follow
Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
Active
Contract Opportunity
Notice ID
75N95025R00005
Related Notice
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH NIDA
Looking for contract opportunity help?

APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.

APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.

The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).

General Information View Changes
  • Contract Opportunity Type: Combined Synopsis/Solicitation (Updated)
  • Updated Published Date: Jan 14, 2025 01:45 pm EST
  • Original Published Date: Nov 30, 2024 04:24 pm EST
  • Updated Date Offers Due: Feb 03, 2025 03:00 pm EST
  • Original Date Offers Due: Feb 03, 2025 03:00 pm EST
  • Inactive Policy: 15 days after date offers due
  • Updated Inactive Date: Feb 18, 2025
  • Original Inactive Date: Feb 18, 2025
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
  • NAICS Code:
    • 325412 - Pharmaceutical Preparation Manufacturing
  • Place of Performance:
    Rockville , MD 20850
    USA
Description

The Therapeutic Development Branch (TDB) within the Division of Preclinical Innovation (DPI) at the National

Center for Advancing Translational Sciences (NCATS) conducts translational research in the area of human

therapeutics development.





The scope of this contract is for Chemistry, Manufacturing, and Control (CMC) services for Drug Products. The

objective of these support services is to ensure receipt of formulated Drug Product (DP) of sufficient quality and quantity to support preclinical, IND-enabling and clinical studies.





The Contractor shall provide support for a broad range of preclinical services required for the design, development,

manufacture, and release of DP, and release of DP as Clinical Trial Material (CTM), including precursors, preliminary

states, Reference Standards (RS) and all required testing. Ancillary products (e.g., placebos, diluents, adjuvants,

master cell banks, testing standards, reference materials) and other materials manufactured or purchased to

support clinical trials or CMC activities may also be required. All activities preliminary to manufacturing in

accordance with current Good Manufacturing Practice (cGMP) may be required (e.g., development or engineering

lots, formulation studies), even without an associated cGMP manufacturing task. All activities required to maintain

material in a usable state, including storage, shipping, testing (in process, release, stability, and quality actions),

and preparation of documents to support regulatory submissions may also be required.





Product formats may include small molecules, short oligomeric compounds, biological (large) molecules,

quaternary molecular assemblies (homogenous or heterogenous), vectors for gene therapy, nanoparticles, and any

of the above modified genetically, biologically, or chemically. Novel formats identified after this draft might also be

needed. Formats could also include Devices or Combination Products. The breadth of this Statement of Work (SOW) includes capabilities to support a range of activities differing in size,

complexity, and duration.





All applicable attachments in connection with this solicitation are available for download.


Attachments/Links
Contact Information
Contracting Office Address
  • c/o 3WFN MSC 6012 301 N Stonestreet Ave
  • Bethesda , MD 20892
  • USA
Primary Point of Contact
Secondary Point of Contact
History
Get Government Bids Like This by Email Receive daily bid alerts that match your keywords, business categories, and target regions.

See Also

Follow W56KGU-22-R-0ESI BAA Amendment 0009 Active Contract Opportunity Notice ID W56KGU22ROESI Related Notice

DEPT OF DEFENSE

Due by 10/31/2027

Follow Request for Information (RFI) for Navy Collaborative Combat Aircraft Increment 1 Prototype

DEPT OF DEFENSE

Due by 9/18/2026

Follow Distributed Aperture Resilient Terminal System (DARTS) Active Contract Opportunity Notice ID W56KGU-26-R-0230

DEPT OF DEFENSE

Due by 9/30/2026

Follow Sepsis Research Blood Sample Collection Services Active Contract Opportunity Notice ID HT942523P0084

DEPT OF DEFENSE

Due by 10/15/2026

* Disclaimer: This website provides information about bids, requests for proposals (RFPs), or requests for qualifications (RFQs) for convenience only and does not serve as an official public notice. Individuals who wish to respond to or inquire about bids, RFPs, or RFQs should contact the relevant government department directly.